LDS/Medical Tests/Occult Blood, Fecal, Immunochemical Testing (iFOB)

Occult Blood, Fecal, Immunochemical Testing (iFOB)

Subtle blood loss can happen anywhere in the GI tract from the mouth to the colon. Fecal Occult Blood (FOB) is used for detecting hidden blood in stool specimens and in conjunction with the digital rectal examination (DRE), which is a screening test used for colon cancer. A positive result would warrant a follow up with a sigmoidoscopy, colonoscopy, etc. Normally this test is performed on at least three separate samples that are collected on separate days. The sensitivity of one sample is less than 50%, however, when combined with three samples the sensitivity is very close to 100%. Although the sensitivity and specificity of the FOB test is dependent on the presence and amount of blood in the sample, this screening method is the most common and cost effective screening test for colon carcinoma.

The American Cancer Society and Centers for Disease Control recommend an occult blood feces test annually after age 50 to aid in the early detection of colorectal cancer. It is also useful to determine gastrointestinal (GI) bleeding found in a number of gastrointestinal (GI) disorders, including diverticulitis, colitis, and polyps. Early diagnosis and treatment of these problems by fecal occult blood screening has been shown to significantly reduce mortality from colorectal cancer. Three types of assays for fecal occult blood testing are commercially available: Gum Guaiac method, Hematoporphyrin, and Immunochemical Fecal Occult Blood (FOB) Rapid Test. Conventional test methods used for the detection of fecal occult blood do not provide a high degree of accuracy because false positives can be noted from patients that have recently ingested undercooked meat, some certain vegetables, etc. Immunological tests developed to detect human hemoglobin are more accurate and do not require special dietary restrictions on patients.

  • Screening for colon cancer or polyps in the colon or rectum
  • Screening for gastrointestinal bleeding
  • As part of routine physical examinations
  • Examination and monitoring for GI bleeding

Positive in:

  • Colon carcinoma
  • Benign colonic polyps
  • Inflammatory bowel disease
  • Peptic ulcer
  • Gastritis
  • Bleeding due to secondary GI disease such esophageal and gastric cancer
  • Some GI infections and inflammation
  • Arteriovenous malformation
  • Certain drugs such as NSAIDs

False negative in:

  • Vitamin C in excess of 250 mg/day from all sources

Negative

It should be noted that a single positive is significant and there is an obligation to perform sequential testing.
 

 

Gum Guaiac method, Hematoporphyrin, Immunochemical Fecal Occult Blood (FOB) Rapid Test. Usually three consecutive stool samples are collected and smears of the specimens are applied to commercially available guaiac-impregnated slides. The specimens are allowed to dry and are then tested for peroxidase activity via a visible color reaction.

Stool

For at least 48 hours before the collection of the first specimen the patient should avoid turnips, melons, horseradish, and other raw vegetables, red meat, poultry, and fish as these foods can cause false positive results. Aspirin in dosages greater than 325 mg/d, and nonsteroidal anti-inflammatory drugs should be avoided for seven days before and during the testing period. Samples from three consecutive bowel movements are suggested.

Digital Rectal Examination (DRE), Proctosigmoidoscopy or Flexible Sigmoidoscopy, and Colonoscopy, Carcinoembryonic antigen (CEA), Fecal Lactoferrin, Serum Ferritin Iron and Iron binding capacity.

1-3 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Ann Intern Med. 2005;142:81. [PMID: 15657155]
  • Am J Gastroenterol. 2009 Mar;104(3):739-50. [PMID: 19240699]
  • Gastrointest Endosc Clin N Am. 2002 Jan;12(1):11-21. [PMID: 11916154]
  • Gastroenterologist. 1998 Mar;6(1):66-78. [PMID: 9531118]
  • Cancer Metastasis Rev. 1987;6(3):397-411. [PMID: 3319274]
  • Kelsen DP, et al. Principles and Practice of Gastrointestinal Oncology. 2nd Philadelphia. Lippincott Williams & Wilkins (2007).
  • Corman ML. Colon and Rectal Surgery. 5th Philadelphia. Lippincott Williams & Wilkins (2005).